AstraZeneca

Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche's Tecentriq Results in NSCLC
Evotec, Takeda Deal; AZ COVID Vaccine US Trials; Promega’s Recognition; Roche’s Tecentriq R...

Promega Biotech Ibérica Gains Recognition for COVID-19 Response in Spain Promega Biotech Ibérica has been heralded as the business leader in Spain for its COVID-19 response. The company’s innov...


Evotec, Chinook's CKD Therapy; Junshi, AZ with Toripalimab in China
Evotec, Chinook Teams Up for CKD Therapy; HitGen & UPPTHERA in Drug Delivery Research; Artiv...

Evotec, Chinook Therapeutics to Advance Chronic Kidney Diseases Therapy Market Evotec and Chinook Therapeutics have collaborated to develop and discover precision medicine therapies for patient...


Biohaven's Troriluzole; Daiichi/ AZ's Enhertu; Fujifilm Manufacturing Units
Biohaven’s Troriluzole Failure; Daiichi/ AZ’s Enhertu; Fujifilm & Manufacturing ...

Biohaven's Troriluzole Dwindles Again In Alzheimer’s After Anxiety  Biohaven Pharmaceuticals had put too much faith in its third-generation prodrug, Troriluzole. The company has tested the...


Historic win for Pfizer's COVID-19 Vaccine; Alexion Buyout; and more
FTA for Gannex’s ASC4; Disappointment for Incyte’s Ruxolitinib; Historic win for Pfizer, BioNTech...

Gannex received US FDA fast track designation for its NASH drug, ASC42 an FXR Agonist Gannex Pharma has received Fast Track designation approval from FDA for its drug candidate ASC42 for non-al...


recent-pharma-biotech-news-updates-for-astrazeneca-uniqure-csl
AstraZeneca’s COVID-19 vaccine; Type 1 diabetes research updates; FDA nod to Zebra’s X-ray ...

AstraZeneca’s COVID-19 vaccine data suggest single-dose efficacy The full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a...


recent-pharma-news-and-updates-for-az-alkermes-innovent-lillys-avenue
US/AZ deal; Alkermes’ Schizophrenia drug; Innovent/Lilly’s China market expansion; Re...

U.S., AstraZeneca strikes an antibody treatment USD 486 million deal The U.S. government awarded the pharma giant AstraZeneca a sum of USD 486 million for the development of up to 100,000 coron...


COVID-19 Vaccine News-Inovio, AZ, J&J; Latest HES Rare Disease News
Inovio’s COVID vaccine trial On-hold; Appeal to Pfizer; XtalPi’s massive raise; GSK N...

Inovio’s shares plunge after FDA holds-off its COVID-19 vaccine Phase II/III trial  Inovio’s COVID-19 vaccine, INO-4800, Phase II/III clinical trials’ have been put under partial hold afte...


Gastroparesis market size
New Hopes; New Horizons: Gastroparesis Market Has Mighty Treatment Options On Its Sleeves

The Gastroparesis market size in the 7MM was found to be USD 3,170.01 million in 2019 and is anticipated to increase at a CAGR for the study period 2017-2030 owing to dynamic pipeline therapies in...


COVID-19-vaccine-development-updates-in-india
In The Global Race For The COVID-19 Vaccine, India Stands As A Strong Player

India registered its first COVID-19 case on 30-January-2020 in Kerala. The cases since then are on a continuous rise. The Government of India in order to contain the spread of novel coronavirus ro...


Pharma happenings and latest COVID-19 News
AZ shows positive results for its COVID-19 vaccine; Synairgen offers a new approach to address CO...

AstraZeneca demonstrates positive early results from its trial evaluating COVID-19 vaccine-AZD1222 In a frenzied race to find a global cure for COVID-19, several pharma players are testing wat...